Redeye thinks that Lagercrantz yet again showed resiliency with strong margins and cash flow despite a drop in organic sales. We believe the company will continue to deliver strong growth from acquisitions in the coming quarters while organic growth will likely be soft. With the positive share price development in the last months we think there is limited room for multiple appreciation and that EPS growth will drive the stock price onwards.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

© Modular Finance, source Nordic Press Releases